Genetic manipulation of radiosensitivity.
Begg
A C
AC
Division of Experimental Therapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Abegg@nki.nl
Vens
C
C
D002453:Cell Cycle / Q000502:physiology; D004249:DNA Damage; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000502:physiology; D006801:Humans; D020928:Mitogen-Activated Protein Kinases / Q000502:physiology; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism*; D009369:Neoplasms / Q000235:genetics / Q000532:radiotherapy*; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D011836:Radiation Tolerance / Q000235:genetics*; D011853:Radiobiology; D015398:Signal Transduction; D014157:Transcription Factors / Q000502:physiology; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism
D004268:DNA-Binding Proteins; D009363:Neoplasm Proteins; D016376:Oligonucleotides, Antisense; D014157:Transcription Factors; D016159:Tumor Suppressor Protein p53; D020928:Mitogen-Activated Protein Kinases